Tue Oct 11, 2022 – 11:50 am EDT
(Association of American Physicians and Surgeons) – The Association of American Physicians and Surgeons (AAPS) filed its motion and amicus brief late last month with the federal district court in Galveston urging it to allow the lawsuit to proceed against the Food and Drug Administration (FDA) for its misleading statements against ivermectin.
In Apter v. HHS, a group of physicians sued to hold the FDA, a federal agency within the Department of Health & Human Services (HHS), accountable for its interference with physicians’ ability to treat COVID-19.
“Defendant FDA has improperly exploited misunderstandings about the legality and prevalence of off-label uses of medication, in order to mislead courts, state medical boards, and the public into thinking there is anything improper about off-label prescribing,” AAPS wrote in its amicus brief to the court. “Not only is off-label prescribing fully proper, legal, and commonplace, but it is also absolutely necessary in order to give effective care to patients.”
Yet the FDA published multiple statements and sent letters to influential organizations to falsely disparage ivermectin, implying that it was not approved for treating COVID-19. Many, including courts and state medical boards,
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors